108 related articles for article (PubMed ID: 18312829)
1. IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
Song PJ; Bernard S; Sarradin P; Vergote J; Barc C; Chalon S; Kung MP; Kung HF; Guilloteau D
Nucl Med Biol; 2008 Feb; 35(2):197-201. PubMed ID: 18312829
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes.
Song PJ; Barc C; Arlicot N; Guilloteau D; Bernard S; Sarradin P; Chalon S; Garreau L; Kung HF; Lantier F; Vergote J
Mol Imaging Biol; 2010 Dec; 12(6):576-82. PubMed ID: 20376566
[TBL] [Abstract][Full Text] [Related]
3. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and characterization of [(124)I]IMPY, a thioflavin-S derivative, in transgenic mouse models of Alzheimer's disease.
Chang KW; Chen CC; Lee SY; Shen LH; Wang HE
Appl Radiat Isot; 2009; 67(7-8):1397-400. PubMed ID: 19307132
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
[TBL] [Abstract][Full Text] [Related]
7. Iodinated tracers for imaging amyloid plaques in the brain.
Kung HF; Kung MP; Zhuang ZP; Hou C; Lee CW; Plössl K; Zhuang B; Skovronsky DM; Lee VM; Trojanowski JQ
Mol Imaging Biol; 2003; 5(6):418-26. PubMed ID: 14667496
[TBL] [Abstract][Full Text] [Related]
8. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
9. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
[TBL] [Abstract][Full Text] [Related]
11. Targeting prion amyloid deposits in vivo.
Sadowski M; Pankiewicz J; Scholtzova H; Tsai J; Li Y; Carp RI; Meeker HC; Gambetti P; Debnath M; Mathis CA; Shao L; Gan WB; Klunk WE; Wisniewski T
J Neuropathol Exp Neurol; 2004 Jul; 63(7):775-84. PubMed ID: 15290902
[TBL] [Abstract][Full Text] [Related]
12. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
13. Characterization of radioiodinated ligand binding to amyloid beta plaques.
Kung MP; Zhuang ZP; Hou C; Jin LW; Kung HF
J Mol Neurosci; 2003; 20(3):249-54. PubMed ID: 14501004
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.
Kung MP; Zhuang ZP; Hou C; Kung HF
J Mol Neurosci; 2004; 24(1):49-53. PubMed ID: 15314249
[TBL] [Abstract][Full Text] [Related]
16. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques.
Seneca N; Cai L; Liow JS; Zoghbi SS; Gladding RL; Hong J; Pike VW; Innis RB
Nucl Med Biol; 2007 Aug; 34(6):681-9. PubMed ID: 17707808
[TBL] [Abstract][Full Text] [Related]
17. Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain.
Cui M; Ono M; Kimura H; Liu B; Saji H
Bioorg Med Chem Lett; 2011 Jul; 21(14):4193-6. PubMed ID: 21684159
[TBL] [Abstract][Full Text] [Related]
18. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M
Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614
[TBL] [Abstract][Full Text] [Related]
19. Novel (E)-5-styryl-2,2'-bithiophene derivatives as ligands for β-amyloid plaques.
Cui M; Li Z; Tang R; Jia H; Liu B
Eur J Med Chem; 2011 Jul; 46(7):2908-16. PubMed ID: 21531050
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer's disease.
Cui MC; Li ZJ; Tang RK; Liu BL
Bioorg Med Chem; 2010 Apr; 18(7):2777-84. PubMed ID: 20211565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
